Haole Liu

Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway.

Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway.

Journal: Journal of pharmaceutical analysis

Published: April 08, 2025

Intra-aortic infusion of nicotine can induce a novel mouse model of abdominal aortic aneurysm.

Intra-aortic infusion of nicotine can induce a novel mouse model of abdominal aortic aneurysm.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: February 22, 2025

Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms.

Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 11, 2025

The C57BL/6N mouse substrain is a viable model of elastase-induced abdominal aortic aneurysm.

The C57BL/6N mouse substrain is a viable model of elastase-induced abdominal aortic aneurysm.

Journal: Frontiers in cardiovascular medicine

Published: July 23, 2024

Cysteine Leukotriene Receptor Antagonist-Montelukast-Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice.

Cysteine Leukotriene Receptor Antagonist-Montelukast-Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice.

Journal: Cardiovascular therapeutics

Published: June 11, 2024

Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway.

Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: December 02, 2023

The incidence rate and histological characteristics of intimal hyperplasia in elastase-induced experimental abdominal aortic aneurysms in mice.

The incidence rate and histological characteristics of intimal hyperplasia in elastase-induced experimental abdominal aortic aneurysms in mice.

Journal: Animal models and experimental medicine

Published: June 12, 2023

C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysms.

C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysms.

Journal: Frontiers in immunology

Published: June 02, 2023

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits.

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits.

Journal: International journal of molecular sciences

Published: January 19, 2023

Genetic deficiency of protein inhibitor of activated STAT3 suppresses experimental abdominal aortic aneurysms.

Genetic deficiency of protein inhibitor of activated STAT3 suppresses experimental abdominal aortic aneurysms.

Journal: Frontiers in cardiovascular medicine

Published: December 01, 2022

Deficiency of protein inhibitor of activated STAT3 exacerbates atherosclerosis by modulating VSMC phenotypic switching.

Deficiency of protein inhibitor of activated STAT3 exacerbates atherosclerosis by modulating VSMC phenotypic switching.

Journal: Atherosclerosis

Published: November 09, 2022

Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice.

Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice.

Journal: Oxidative medicine and cellular longevity

Published: December 11, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026